Ophirex

About Ophirex

Ophirex is a public benefit corporation dedicated to improving global health by developing affordable and accessible oral treatments for snakebite victims. Operating in the healthcare sector, Ophirex targets vulnerable populations in rural areas where snakebites are prevalent, such as farmers, herders, and fishers. The company aims to address the significant health and socio-economic impacts of snakebites, which affect an estimated 5.4 million people annually, with over 500,000 resulting in death or severe injury. Ophirex's business model focuses on creating lifesaving antidotes that can be administered immediately, without the need for medical professionals, thereby reducing fatalities and long-term disabilities. Revenue is generated through the sale of these treatments to governments, non-governmental organizations, and healthcare providers in snakebite-prone regions. By offering a cost-effective solution, Ophirex not only saves lives but also alleviates the financial burden on affected families.